Adélie Gothland

Title: Adélie Gothland: Innovator in Cyclodextrin Technology

Introduction

Adélie Gothland, based in Paris, France, is an inventive mind in the field of pharmaceutical science. With a focus on cyclodextrin technology, Gothland has made significant contributions through his unique patent. His work emphasizes the importance of innovative solutions in drug delivery and materials science.

Latest Patents

Adélie Gothland holds a patent for a "Capped cyclodextrin-hydrophobic moiety conjugate, cyclodextrin supramolecular polymer, and cyclodextrin-siRNA complex and method of synthesis thereof." This inventive concept includes a capped cyclodextrin-hydrophobic moiety conjugate that is particularly useful in creating supramolecular polymers and siRNA-cyclodextrin complexes. The patent outlines a method for synthesizing these complexes, which can have various applications in the pharmaceutical sector.

Career Highlights

Throughout his career, Gothland has worked at prestigious institutions such as Sorbonne Université and the Centre National de la Recherche Scientifique, contributing to advanced research and innovation in chemistry and biomedicine. His expertise has positioned him as a valuable asset in the scientific community, particularly in areas associated with cyclodextrin applications.

Collaborations

Adélie Gothland has collaborated with notable experts in his field, including Matthieu Sollogoub and Vincent Calvez. These partnerships have enhanced his research efforts and the overall outcomes of his projects, showcasing the importance of teamwork in advancing scientific knowledge and technology.

Conclusion

Adélie Gothland's innovative approach and patent in cyclodextrin technology reflect his commitment to improving pharmaceutical applications. His contributions not only highlight the potential of his inventions but also emphasize the collaborative nature of scientific progress.